课题基金 / 基金详情

The role of the PGC master regulators Blimp1, Prdm14 and Tfap2c on the licensing of germ cells - control of pluripotency and channeling into unipotency

The role of the PGC master regulators Blimp1, Prdm14 and Tfap2c on the licensing of germ cells - control of pluripotency and channeling into unipotency
PGC 主调节因子 Blimp1、Prdm14 和 Tfap2c 在生殖细胞许可中的作用 - 控制多能性和引导至单能性
批准号:
284859850
负责人:
Professor Dr. Hubert Schorle
金额:
$0.0万
依托单位:
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2015
资助国家:
德国
项目状态:
已结题
起止时间:
2014-12-31 至 2019-12-31

项目摘要

项目成果

Professor Dr. Hubert Schorle的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Germ cells propagate the species. In mammals, germ cells are specified as primpordial germ cells (PGCs) in the early embryo. They migrate to the gonads where they differentiate further to form egg and sperm. In this process, pluripotent cells of the epiblast give rise to latent pluripotent cells (PGCs), which are channeled, into unipotency (egg and sperm). The control of the latent pluripotency and the channeling into unipotency is a poorly understood process. The fact that perturbations of the molecular cascades lead to sterility and/or germ cell tumors demonstrates that more knowledge about this process is mandatory.We propose to analyze germ cell specific gain of function transgenic mice overexpressing the germ cell specifiying genes Tfap2c, Blimp1 and Prdm14. We will analyze the gonads at various times during development and will bring PGCs in culture to derive embryonic germ cells. We envision that the transgenes allow for prolonged derivation of EG cells (in wildtype only up to day E 10.5), which will indicate a perturbation in canalization into unipotency. This defect might lead to the development of germ cell tumors, which, in the human situation are hallmarked by persistent expression of TFAP2C and BLIMP1. PRDM14 has been implicated in germ cell tumors by a GWAS study recently. We hypothesize, that each transgene will elicit a rather specific change in gene expression leading to a different type of tumor. In addition, we will transplant the EG-cells under the skin and monitor tumor formation. This will be compared to the tumorigenesis in the testes and will allow a comparison of the tumor-microenvironment (somatic vs. testes). The application is based on the impression of a recent sabbatical. The experiments might appear ambitious, but the applicant will cooperate with the ex-sabbatical lab of Prof. Dr. D. Page (MIT) in terms of germ cell development, and with Prof. Dr. D. deRooij (who was also visiting scientist at the Page lab at this time) to achieve all goals described.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular mechanisms of direct reprogramming of fibroblasts to trophoblast stem cells
  • 批准号:
    329123747
  • 项目类别:
    Research Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    2017
  • 负责人:
    Professor Dr. Hubert Schorle
  • 依托单位:
Analyses of the consequences of a protamine-2-deficiency in mouse and man: molecular mechanisms, reactive oxygen species and an approach to therapy.
  • 批准号:
    278559200
  • 项目类别:
    Research Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    2015
  • 负责人:
    Professor Dr. Hubert Schorle
  • 依托单位:
Die Interaktion von Connexin31 und AP-2gamma in der Trophoblast "lineage" Differenzierung für die Erhaltung des Stammzellpotenzials der Trophoblastzellen während der Plazentadifferenzierung
  • 批准号:
    164169905
  • 项目类别:
    Research Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    2010
  • 负责人:
    Professor Dr. Hubert Schorle
  • 依托单位:
Die Regulation der Genexpression während der fetalen Spermatogenese im Vergleich zu gestörter Spermatogenese und Keimzelltumoren
  • 批准号:
    27951430
  • 项目类别:
    Research Grants
  • 资助金额:
    $0.0万
  • 财政年份:
    2006
  • 负责人:
    Professor Dr. Hubert Schorle
  • 依托单位:
国内基金
海外基金
基于SIRT1/PGC-1α信号通路探讨益心泰调控线粒体生物发生治疗慢性心力衰竭的机制研究
活血荣络方通过PGC-1α/SIRT5轴调控线粒体动力蛋白去琥珀酰化改善脑缺血再灌注损伤的机制研究
NEDD4L调控STK11泛素化通过SIRT1/PGC1α介导线粒体稳态失衡抑制hMSCs成骨分化的机制研究
  • 批准号:
    2026JJ81912
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    董娜
  • 依托单位:
SIRT1/PGC-1α信号轴调节线粒体葡萄糖代谢对人皮肤鳞状细胞癌作用机制研究
  • 批准号:
    2026JJ82418
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    来立娟
  • 依托单位: